BUSINESS● LOWAug 14 · Aug 14, 2026, 6:01 AM
Zentalis Pharmaceuticals slides after pricing 23M share public offering at $3.50/share
Seeking Alpha Tech
Zentalis Pharmaceuticals experienced a decline in stock value after pricing a public offering of 23 million shares at $3.50 per share. This event is significant for investors following the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS43m agoGold market consolidating rather than entering bear market, Metals Focus analyst saysSeeking Alpha TechBUSINESS44m agoCollegium resolves Nucynta patent dispute with GrünenthalSeeking Alpha Tech